Home / Topics / early access programs

early access programs Podcasts

1 episode about early access programs

Rhythm Pharmaceuticals, Inc. (RYTM) Announced Q1 2026 Earnings on May 5, 2026, Reporting "Revenues for the quarter were $60 million." artwork

Rhythm Pharmaceuticals, Inc. (RYTM) Announced Q1 2026 Earnings on May 5, 2026, Reporting "Revenues for the quarter were $60 million."
Rhythm Pharmaceuticals Inc. (RYTM)
• 17:56 •Ep 146 •The Earnings Debate •▶ Play on Apple